文献速递临床试验与 GCP真实世界研究与卫生经济

Dulce Digital-Me:针对医疗服务不足的西班牙裔糖尿病患者的适应性移动健康干预随机对照试验方案

Dulce Digital-Me: protocol for a randomized controlled trial of an adaptive mHealth intervention for underserved Hispanics with diabetes.
PubMed 文献 · Trials · 2022-01-28

该方案计划纳入414名低收入且血糖控制不佳的西班牙裔2型糖尿病成人,随机分为Dulce Digital、Dulce Digital-Me-Automated和Dulce Digital-Me-Telephonic三组,随访12个月,比较三组对糖化血红蛋白(主要结局)、低密度脂蛋白胆固醇和收缩压的改善效果及成本效益。

要点

  • 三臂平行随机试验,等比例分配,纳入圣迭戈县联邦合格健康中心的西班牙裔2型糖尿病成人(N=414)。
  • 干预组在Dulce Digital基础上增加个性化目标设定与反馈,分别通过算法驱动的自动短信或照护团队健康教练电话传递,随访12个月。
  • 主要结局为糖化血红蛋白,同时评估低密度脂蛋白胆固醇、收缩压、患者-提供者沟通、用药及自我管理依从性和成本效益。

核心结论

  • 该研究旨在比较三种移动健康干预在改善西班牙裔2型糖尿病患者临床控制、患者-提供者沟通、依从性及成本效益方面的差异,以阐明技术如何最有效、高效地整合入初级保健慢性病照护模式。

研究设计与样本

  • 三臂、平行组、等比例分配的随机对照试验,纳入圣迭戈县联邦合格健康中心的低收入且血糖控制不佳的西班牙裔2型糖尿病成人(N=414)。
  • 参与者随机接受Dulce Digital、Dulce Digital-Me-Automated或Dulce Digital-Me-Telephonic干预,随访12个月。
  • DD-Me组在Dulce Digital components基础上增加个性化目标设定与反馈,通过算法驱动的自动短信(DD-Me-Automated)或照护团队健康教练电话(DD-Me-Telephonic)传递。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: By 2034, the number of US individuals with diabetes is predicted to increase from 23.7 to 44.1 million, and annual diabetes-related spending is expected to grow from $113 to $336 billion. Up to 55% of US Hispanics born in the year 2000 are expected to develop diabetes during their lifetime. Poor healthcare access and cultural barriers prevent optimal care, adherence, and clinical benefit, placing Hispanics at disproportionate risk for costly diabetes complications. Mobile technology is increasingly prevalent in all populations and can circumvent such barriers. Our group developed Dulce Digital, an educational text messaging program that improved glycemic control relative to usual care. Dulce Digital-Me (DD-Me) has been tailored to a participant's individual needs with a greater focus on health behavior change. METHODS: This is a three-arm, parallel group, randomized trial with equal allocation ratio enrolling Hispanic adults with low income and poorly managed type 2 diabetes (N = 414) from a San Diego County Federally Qualified Health Center. Participants are randomized to receive Dulce Digital, Dulce Digital-Me-Automated, or Dulce Digital-Me-Telephonic. The DD-Me groups include Dulce Digital components plus personalized goal-setting and feedback delivered via algorithm-driven automated text messaging (DD-Me-Automated) or by the care team health coach (DD-Me-Telephonic) over a 12-month follow-up period. The study will examine the comparative effectiveness of the three groups in improving diabetes clinical control [HbA1c, primary outcome; low-density lipoprotein cholesterol (LDL-C), and systolic blood pressure (SBP)] and patient-provider communication and patient adherence (i.e., medication, self-management tasks) over 12 months and will examine cost-effectiveness of the three interventions. DISCUSSION: Our comparative evaluation of three mHealth approaches will elucidate how technology can be integrated most effectively and efficiently within primary care-based chronic care model approaches to reduce diabetes disparities in Hispanics and will assess two modes of personalized messaging delivery (i.e., automated messaging vs. telephonic by health coach) to inform cost and acceptability. TRIAL REGISTRATION: NCT03130699-All items from the WHO Trial Registration data set are available in https://clinicaltrials.gov/ct2/show/study/NCT03130699 .

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Philis-Tsimikas A, Fortmann AL, Godino JG, et al. Dulce Digital-Me: protocol for a randomized controlled trial of an adaptive mHealth intervention for underserved Hispanics with diabetes. Trials. 2022. PMID: 35090520. doi:10.1186/s13063-021-05899-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。